Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 49 | 2025 | 104 | 21.160 |
Why?
|
| Neuropsychological Tests | 50 | 2025 | 137 | 9.020 |
Why?
|
| Memory, Episodic | 19 | 2025 | 36 | 8.100 |
Why?
|
| Health Literacy | 14 | 2024 | 28 | 7.240 |
Why?
|
| Activities of Daily Living | 17 | 2024 | 46 | 6.110 |
Why?
|
| Executive Function | 15 | 2025 | 61 | 5.530 |
Why?
|
| Cognition | 23 | 2025 | 140 | 5.340 |
Why?
|
| Humans | 87 | 2025 | 4936 | 4.720 |
Why?
|
| Cognitive Dysfunction | 15 | 2024 | 55 | 4.540 |
Why?
|
| Aged | 42 | 2024 | 703 | 4.400 |
Why?
|
| Memory Disorders | 12 | 2024 | 36 | 4.330 |
Why?
|
| Middle Aged | 38 | 2025 | 967 | 3.540 |
Why?
|
| Quality of Life | 7 | 2024 | 87 | 2.940 |
Why?
|
| Adult | 30 | 2025 | 1567 | 2.390 |
Why?
|
| Aging | 12 | 2024 | 109 | 2.380 |
Why?
|
| Male | 36 | 2025 | 2491 | 2.350 |
Why?
|
| Female | 36 | 2025 | 2523 | 2.330 |
Why?
|
| Periodicals as Topic | 3 | 2023 | 8 | 2.120 |
Why?
|
| Neuropsychology | 5 | 2023 | 8 | 1.960 |
Why?
|
| Internet | 5 | 2022 | 34 | 1.860 |
Why?
|
| Young Adult | 16 | 2025 | 787 | 1.810 |
Why?
|
| Memory | 4 | 2023 | 39 | 1.740 |
Why?
|
| Epilepsy | 2 | 2024 | 11 | 1.680 |
Why?
|
| Apathy | 5 | 2024 | 8 | 1.560 |
Why?
|
| Cross-Sectional Studies | 16 | 2025 | 269 | 1.550 |
Why?
|
| Aged, 80 and over | 13 | 2024 | 262 | 1.520 |
Why?
|
| Depression | 4 | 2024 | 125 | 1.480 |
Why?
|
| Consumer Health Information | 2 | 2022 | 2 | 1.380 |
Why?
|
| Attention | 3 | 2020 | 66 | 1.370 |
Why?
|
| Psychomotor Performance | 6 | 2025 | 78 | 1.360 |
Why?
|
| Cognition Disorders | 5 | 2024 | 21 | 1.160 |
Why?
|
| Cues | 4 | 2021 | 34 | 1.120 |
Why?
|
| Retrospective Studies | 9 | 2025 | 341 | 1.110 |
Why?
|
| Neurocognitive Disorders | 4 | 2023 | 5 | 1.080 |
Why?
|
| AIDS Dementia Complex | 3 | 2022 | 4 | 1.070 |
Why?
|
| Adolescent | 12 | 2024 | 758 | 1.060 |
Why?
|
| Alzheimer Disease | 3 | 2024 | 62 | 1.060 |
Why?
|
| Cognitive Aging | 3 | 2024 | 7 | 1.040 |
Why?
|
| Mental Recall | 6 | 2023 | 18 | 1.020 |
Why?
|
| Verbal Learning | 3 | 2021 | 12 | 0.990 |
Why?
|
| Telemedicine | 3 | 2022 | 37 | 0.990 |
Why?
|
| Surveys and Questionnaires | 7 | 2024 | 258 | 0.960 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2021 | 47 | 0.930 |
Why?
|
| Prospective Studies | 6 | 2023 | 111 | 0.910 |
Why?
|
| Biological Variation, Individual | 1 | 2025 | 1 | 0.890 |
Why?
|
| Pharmaceutical Services, Online | 2 | 2021 | 4 | 0.860 |
Why?
|
| Independent Living | 2 | 2021 | 12 | 0.850 |
Why?
|
| Lewy Body Disease | 2 | 2024 | 2 | 0.830 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2022 | 19 | 0.830 |
Why?
|
| HIV Long-Term Survivors | 1 | 2023 | 1 | 0.810 |
Why?
|
| Self Concept | 1 | 2023 | 18 | 0.800 |
Why?
|
| Patient Portals | 1 | 2023 | 3 | 0.770 |
Why?
|
| Reproducibility of Results | 9 | 2025 | 318 | 0.740 |
Why?
|
| Racism | 1 | 2021 | 17 | 0.700 |
Why?
|
| Self Report | 4 | 2023 | 67 | 0.690 |
Why?
|
| Self-Management | 1 | 2021 | 3 | 0.690 |
Why?
|
| Technology | 1 | 2021 | 6 | 0.680 |
Why?
|
| Publishing | 1 | 2020 | 2 | 0.660 |
Why?
|
| Semantics | 1 | 2021 | 22 | 0.660 |
Why?
|
| Social Environment | 1 | 2020 | 12 | 0.650 |
Why?
|
| Health Behavior | 4 | 2021 | 34 | 0.650 |
Why?
|
| Information Seeking Behavior | 1 | 2020 | 2 | 0.640 |
Why?
|
| Aptitude | 1 | 2020 | 9 | 0.640 |
Why?
|
| Intelligence | 1 | 2020 | 28 | 0.640 |
Why?
|
| Motivation | 1 | 2021 | 69 | 0.630 |
Why?
|
| Dementia | 1 | 2020 | 50 | 0.580 |
Why?
|
| Telephone | 3 | 2024 | 13 | 0.580 |
Why?
|
| Psychometrics | 5 | 2024 | 94 | 0.580 |
Why?
|
| Pandemics | 3 | 2023 | 73 | 0.510 |
Why?
|
| HIV Seronegativity | 3 | 2023 | 4 | 0.400 |
Why?
|
| Age Factors | 2 | 2024 | 65 | 0.390 |
Why?
|
| Self Efficacy | 3 | 2023 | 34 | 0.390 |
Why?
|
| Factor Analysis, Statistical | 2 | 2023 | 39 | 0.370 |
Why?
|
| Depressive Disorder, Major | 2 | 2023 | 17 | 0.360 |
Why?
|
| Pilot Projects | 2 | 2022 | 98 | 0.350 |
Why?
|
| Biomarkers | 2 | 2023 | 81 | 0.340 |
Why?
|
| Memory and Learning Tests | 2 | 2020 | 3 | 0.320 |
Why?
|
| Consensus | 3 | 2025 | 12 | 0.320 |
Why?
|
| Decision Making | 2 | 2020 | 9 | 0.310 |
Why?
|
| United States | 2 | 2021 | 495 | 0.290 |
Why?
|
| Delphi Technique | 2 | 2025 | 8 | 0.270 |
Why?
|
| Reference Values | 2 | 2024 | 26 | 0.250 |
Why?
|
| Checklist | 1 | 2025 | 3 | 0.220 |
Why?
|
| Prodromal Symptoms | 1 | 2024 | 1 | 0.220 |
Why?
|
| Frontotemporal Dementia | 1 | 2024 | 2 | 0.210 |
Why?
|
| Science | 1 | 2024 | 6 | 0.210 |
Why?
|
| Financial Management | 1 | 2024 | 3 | 0.210 |
Why?
|
| Veterans | 1 | 2024 | 17 | 0.210 |
Why?
|
| Vascular Diseases | 1 | 2024 | 4 | 0.210 |
Why?
|
| Disabled Persons | 1 | 2024 | 11 | 0.210 |
Why?
|
| Social Support | 1 | 2024 | 28 | 0.210 |
Why?
|
| Regression Analysis | 1 | 2023 | 30 | 0.200 |
Why?
|
| Interview, Psychological | 1 | 2023 | 14 | 0.200 |
Why?
|
| Psychological Tests | 1 | 2023 | 9 | 0.200 |
Why?
|
| Protective Factors | 1 | 2023 | 8 | 0.200 |
Why?
|
| Risk Factors | 1 | 2024 | 159 | 0.200 |
Why?
|
| Multivariate Analysis | 1 | 2023 | 15 | 0.190 |
Why?
|
| Health Personnel | 1 | 2023 | 20 | 0.190 |
Why?
|
| HIV | 1 | 2023 | 3 | 0.190 |
Why?
|
| tau Proteins | 1 | 2023 | 6 | 0.190 |
Why?
|
| Learning | 2 | 2020 | 44 | 0.190 |
Why?
|
| Literacy | 1 | 2022 | 1 | 0.190 |
Why?
|
| Prescription Drug Misuse | 1 | 2023 | 9 | 0.190 |
Why?
|
| Behavior, Addictive | 1 | 2022 | 8 | 0.190 |
Why?
|
| Creativity | 1 | 2022 | 1 | 0.190 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 27 | 0.190 |
Why?
|
| Cohort Studies | 1 | 2023 | 115 | 0.190 |
Why?
|
| Chronic Pain | 1 | 2023 | 22 | 0.190 |
Why?
|
| Intention | 1 | 2022 | 19 | 0.180 |
Why?
|
| Trust | 1 | 2022 | 9 | 0.180 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 47 | 0.180 |
Why?
|
| Post-Concussion Syndrome | 1 | 2022 | 4 | 0.180 |
Why?
|
| Athletic Injuries | 1 | 2022 | 4 | 0.180 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 34 | 0.180 |
Why?
|
| Authorship | 1 | 2021 | 4 | 0.180 |
Why?
|
| Brain Concussion | 1 | 2022 | 7 | 0.180 |
Why?
|
| Bibliometrics | 1 | 2021 | 7 | 0.180 |
Why?
|
| Neurons | 1 | 2023 | 109 | 0.170 |
Why?
|
| Proton Therapy | 1 | 2021 | 4 | 0.170 |
Why?
|
| Laboratories | 1 | 2021 | 4 | 0.170 |
Why?
|
| Educational Status | 1 | 2021 | 29 | 0.170 |
Why?
|
| Imagination | 1 | 2021 | 3 | 0.170 |
Why?
|
| Medication Therapy Management | 1 | 2021 | 6 | 0.170 |
Why?
|
| Individuality | 1 | 2021 | 15 | 0.170 |
Why?
|
| Chronic Disease | 1 | 2021 | 25 | 0.170 |
Why?
|
| Cancer Survivors | 1 | 2021 | 14 | 0.170 |
Why?
|
| Cluster Analysis | 1 | 2021 | 22 | 0.170 |
Why?
|
| Employment | 1 | 2021 | 9 | 0.170 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 25 | 0.170 |
Why?
|
| Acoustic Stimulation | 1 | 2021 | 17 | 0.170 |
Why?
|
| Risk-Taking | 1 | 2020 | 14 | 0.160 |
Why?
|
| Child | 2 | 2021 | 627 | 0.160 |
Why?
|
| Sexism | 1 | 2020 | 3 | 0.160 |
Why?
|
| Medicare | 1 | 2021 | 78 | 0.160 |
Why?
|
| Wechsler Scales | 1 | 2020 | 4 | 0.160 |
Why?
|
| Intelligence Tests | 1 | 2020 | 10 | 0.160 |
Why?
|
| Sexual Behavior | 1 | 2020 | 27 | 0.160 |
Why?
|
| Personality | 1 | 2021 | 48 | 0.160 |
Why?
|
| HIV Seropositivity | 1 | 2020 | 4 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 7 | 0.160 |
Why?
|
| Reaction Time | 1 | 2021 | 52 | 0.160 |
Why?
|
| Personality Disorders | 1 | 2021 | 38 | 0.160 |
Why?
|
| Comprehension | 1 | 2020 | 31 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 8 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 8 | 0.160 |
Why?
|
| Social Determinants of Health | 1 | 2020 | 10 | 0.160 |
Why?
|
| Huntington Disease | 1 | 2020 | 2 | 0.160 |
Why?
|
| Time Perception | 1 | 2019 | 5 | 0.150 |
Why?
|
| Mental Disorders | 1 | 2020 | 48 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 102 | 0.150 |
Why?
|
| Language | 1 | 2019 | 51 | 0.150 |
Why?
|
| Translating | 1 | 2022 | 4 | 0.050 |
Why?
|
| Translations | 1 | 2022 | 4 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 73 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 69 | 0.040 |
Why?
|
| Health | 1 | 2021 | 4 | 0.040 |
Why?
|
| Viral Load | 1 | 2021 | 1 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2021 | 3 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2021 | 2 | 0.040 |
Why?
|
| Photons | 1 | 2021 | 8 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2021 | 13 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 4 | 0.040 |
Why?
|
| Anxiety | 1 | 2023 | 167 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 137 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2020 | 12 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 59 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2021 | 69 | 0.040 |
Why?
|